McKesson Cash & Equivalents increased by 30.2% to $3.98B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $5.96B to $3.98B. Over 5 years (FY 2021 to FY 2026), Cash & Equivalents shows a downward trend with a -9.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.54B | $2.53B | $3.16B | $3.94B | $2.34B | $2.96B | $2.78B | $4.68B | $2.64B | $2.52B | $1.98B | $4.59B | $2.30B | $2.51B | $1.28B | $5.96B | $2.68B | $4.11B | $3.05B | $3.98B |
| QoQ Change | — | -0.1% | +24.7% | +24.6% | -40.5% | +26.4% | -6.1% | +68.4% | -43.6% | -4.3% | -21.4% | +131.2% | -49.7% | +9.0% | -48.9% | +364.6% | -55.0% | +53.1% | -25.7% | +30.2% |
| YoY Change | — | — | — | — | -7.7% | +16.8% | -12.1% | +18.9% | +12.7% | -14.7% | -28.6% | -2.0% | -12.6% | -0.5% | -35.4% | +29.9% | +16.4% | +63.6% | +138.1% | -33.3% |